Allogeneic Haematopoietic Stem Cell Transplantation Completed Phase 2 Trials for Busulfan (DB01008)

IndicationStatusPhase
DBCOND0032129 (Allogeneic Haematopoietic Stem Cell Transplantation)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00990249Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell TransplantationTreatment